Remove 2026 Remove Compounding Remove Vaccines
article thumbnail

Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting

Drug Topics

Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.

Vaccines 341
article thumbnail

Turning Reconciliation into a Revenue Growth Engine

Drug Topics

For instance, the MFP is expected to affect approximately 10 drugs in 2026, with the list expanding annually, potentially creating a $22,000 monthly financial impact for average retail pharmacies.

247
247
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Clesrovimab-cfor for Prevention of RSV in Infants

Drug Topics

Exclusion criteria included having a bleeding disorder or having received any vaccine or monoclonal antibody for the prevention of RSV. Merck said in the release that it anticipates ordering of clesrovimab-cfor to begin in July, with shipments being delivered before the start of the 2025-2026 RSV season.

FDA 430
article thumbnail

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Pharmacy Times

USP labs provide unparalleled expertise in developing quality and process standards, establishing and validating analytical methods, characterizing impurities, and synthesizing organic compounds. USP plans to continue expanding its advanced technology footprint into an additional 8,000 square foot laboratory in 2026. Subscribe Now!

article thumbnail

Pneumococcal Burden Remains Despite Immunization Expansion

Drug Topics

Investigators found that incorporating either the pneumococcal conjugate vaccine (PCV) 20 or PCV 15 and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) had an incremental budget impact of $6.5 2,3 In June 2024, the ACIP announced updates to the vaccine schedule to prevent invasive pneumococcal disease.

article thumbnail

Op-Ed: Celebrate Direct-to-Career Paths and Primary Care Pharmacy Practice

Pharmacy Times

Pharmacy schools are expected to graduate 8,000 student pharmacists in 2026…” [Instagram post]. North American Pharmacist Licensure Examination Passing Rates for 2022-2024 Graduates. National Association of Boards of Pharmacy. January 21, 2025. Accessed June 6, 2025. aacpharmacy. March 12, 2025. Accessed June 6, 2025.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

The FDA Law Blog

On November 17th, CMS issued its final guidance on the Discount Program in which it responded to public comments and provided updated guidance for the Discount Program for 2025 and 2026. covered insulin product or vaccine). Manufacturers must sign the agreement by March 1, 2024, to participate in the 2025 plan year.

Labelling 105